Bing

SEARCH HISTORY

FPI dominant sensitive Indian stock markets are already under pressure ... Castleton Investment, incorporated in 1993 and owned by UK-based Welcome Ltd, has shares in GSK India. The Indian unit of Glaxo is listed …
Daily News and Analysis · 7 hours ago
Foreign investors
GlaxoSmithKline’s second-quarter earnings slipped, but not as much as analysts had feared, encouraging investors and sending the pharmaceutical giant’s stock up 3.5 percent in mid-morning trading. In its first earnings report since completing a $20 ...
The News & Observer · ByJohn Murawski · 7/29/2015
(GSK.L, GSK), reported a drop in profit for the second quarter ... our targets for this year and return the Group to earnings growth in 2016." On the London Stock Exchange, Glaxo is trading at 1,374.50 pence, up 46.00 pounds or 3.46%.
NASDAQ · 7/29/2015
Register for your complimentary reports at the links given below. GlaxoSmithKline PLC's stock edged 0.51% higher, to close the day at $41.60. The stock recorded a trading volume of 2.64 million shares, below its three months average volume of 4.00 million ...
Financial Content · 7/28/2015
GlaxoSmithKline PLC
STAN Standard Chartered PLC value of shares traded £81,574,548 RBS Royal Bank of Scotland Group (The) PLC value of shares traded £72,434,551 RIO Rio Tinto PLC value of shares traded £71,508,500 GSK GlaxoSmithKline PLC value of shares …
Stock Market Wire · 29 minutes ago
PLC value
My primary reasons for being bearish on the stock are as follows: As mentioned earlier ... NVS sold its vaccines business to GlaxoSmithKline (NYSE:GSK) for $7.1 billion, and acquired GSK's several oncology products and pipeline compounds for $16 billion.
Seeking Alpha · 1 day ago
NVS
The next five years look much more positive than the Street thinks. What do you see in GlaxoSmithKline? There are three ways the stock can move higher. First, the patent expirations are almost behind it, which will …
Barron's · ByReshma Kapadia · 7/25/2015
Rupal Bhansali
Pharmaceutical giant GlaxoSmithKline (GSK) will have to work hard to address ... Parkes retained his ‘hold’ recommendation and target price of £14.50 on the stock after second quarter results. The shares were …
City Wire · 7/31/2015
shares
GlaxoSmithKline (NYSE:GSK) has potential upside of 9.9% based on a current price of $42.87 and analysts' consensus price target of $47.12. The stock should run into initial resistance at its 50-day moving average (MA) of $43.05 and subsequent …
Financial News Network Online · ByMallory Stone · 7/29/2015
July 29--GlaxoSmithKline's second-quarter earnings slipped, but not as much as analysts had feared, encouraging investors and sending the pharmaceutical giant's stock up 3.5 percent in mid-morning trading. The British drug maker now employs about 4 …
4 Traders · 7/29/2015

GlaxoSmithKline

Company
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world'…
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world's sixth-largest pharmaceutical company in 2014, after Pfizer, Novartis, Sanofi, Hoffmann-La Roche and Merck. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.
Data from: Wikipedia